Treatment of osteoid osteoma – is RFA the future of osteoid osteoma therapy?

Congress:

ECR 2020

Poster Number:

C-12119

Type:

Scientific Exhibit

Keywords:

Performed at one institution, Observational, Retrospective, Multidisciplinary cancer care, Surgery, Removal, Puncture, Percutaneous, MR, CT, Musculoskeletal bone, Interventional non-vascular, Musculoskeletal

Authors:

J. Igrec, I. Brcic, M. Bergovec, R. Igrec, M. A. smolle, B. Liegl-Atzwanger, M. Fuchsjäger, A. Leithner, R. H. Portugaller; Graz/AT

DOI:

10.26044/ecr2020/C-12119

DOI-Link:

https://dx.doi.org/10.26044/ecr2020/C-12119

Methods and materials

From January 2005 to September 2019, 117 patients with OO were studied retrospectively. Patients were selected from a prospectively maintained tumor database using either histological (for those patients undergoing surgery) or radiological diagnosis of OO. Imaging examinations performed during this period were analyzed for the presence of typical imaging findings (CT and MRI) of OO.

The study included 39 females and 78 males with the mean patient age 22.5 years (age range 2 to 60 years). Fig. 7